Locations:
Search IconSearch

News & Insights

AHA-690×380

The Best of AHA 2014

Leading cardiologist picks studies with most impact

PCSK9 Inhibitors

PCSK9 Inhibitors: With Likely Approval Imminent, What Should We Make of Them?

Unprecedented LDL-C reductions raise hopes for long-term outcome trials

Baylor-690×380

Cleveland Clinic Teams with Three Baylor Hospitals to Provide Heart Care

Systems will share clinical, academic and research components

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ezitimibe-690×380

Ezetimibe Adds Incremental Benefit to Statin Therapy

Further lowering LDL reduces risk in post-ACS patients

ClinicalTrials-690×380

Heart & Vascular Clinical Trials

From prevention and pacing to stenting and surgery

AliveCor_Frt_690x380

Interest Grows in Cardiac Monitoring Apps

Rapid acceptance reveals multiple advantages, challenges

BackPage 13 of 14Next

Advertisement

Ad